Posts

French Supreme Court in Finasteride second-medical use litigation acknowledges patentability of dosage regime claims

BREAKING: CJEU holds that SPCs cannot be obtained on the basis of an "end of procedure notice" pursuant to Article 3(b) SPC Regulation